304 related articles for article (PubMed ID: 12208721)
1. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
2. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
5. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
[TBL] [Abstract][Full Text] [Related]
6. Treatment of primary intraocular lymphoma with intravitreal methotrexate.
Sou R; Ohguro N; Maeda T; Saishin Y; Tano Y
Jpn J Ophthalmol; 2008; 52(3):167-174. PubMed ID: 18661266
[TBL] [Abstract][Full Text] [Related]
7. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
8. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
[TBL] [Abstract][Full Text] [Related]
9. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
10. Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood-brain barrier disruption.
Vicuna-Kojchen J; Frenkel S; Siegal T; Shalom E; Chowers I; Pe'er J
Br J Ophthalmol; 2008 Feb; 92(2):231-5. PubMed ID: 18227203
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma.
Tourville E; Tardif Y
Can J Ophthalmol; 2003 Dec; 38(7):598-601. PubMed ID: 14740803
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
Habot-Wilner Z; Frenkel S; Pe'er J
Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
[TBL] [Abstract][Full Text] [Related]
13. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate.
de Smet MD
Bull Soc Belge Ophtalmol; 2001; (279):91-5. PubMed ID: 11344720
[TBL] [Abstract][Full Text] [Related]
14. Eyewash with balanced salt solution after intravitreal methotrexate injection in a case of vitreoretinal lymphoma: a simple but effective way to prevent ocular surface toxicity.
Moharana B; Parija S; Palanisamy S; Mishra P
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474142
[TBL] [Abstract][Full Text] [Related]
15. Corneal epithelial toxicity with intravitreal methotrexate in a case of B-cell lymphoma with ocular involvement.
Sahay P; Maharana PK; Temkar S; Chawla R
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30150351
[TBL] [Abstract][Full Text] [Related]
16. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
Kvopka M; Lake SR; Smith JR
Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
[TBL] [Abstract][Full Text] [Related]
17. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
18. Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
Tyson RM; Siegal T; Doolittle ND; Lacy C; Kraemer DF; Neutwelt EA
Leuk Lymphoma; 2003 Apr; 44(4):627-33. PubMed ID: 12769339
[TBL] [Abstract][Full Text] [Related]
19. The safety of intraocular methotrexate in silicone-filled eyes.
Hardwig PW; Pulido JS; Bakri SJ
Retina; 2008 Oct; 28(8):1082-6. PubMed ID: 18779714
[TBL] [Abstract][Full Text] [Related]
20. Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma.
Hardwig PW; Pulido JS; Erie JC; Baratz KH; Buettner H
Am J Ophthalmol; 2006 Nov; 142(5):883-5. PubMed ID: 17056381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]